These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32746966)

  • 1. Expression of different L1 isoforms of
    Fu Y; Cao R; Schäfer M; Stephan S; Braspenning-Wesch I; Schmitt L; Bischoff R; Müller M; Schäfer K; Vinzón SE; Rösl F; Hasche D
    Elife; 2020 Aug; 9():. PubMed ID: 32746966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development.
    Ahmels M; Mariz FC; Braspenning-Wesch I; Stephan S; Huber B; Schmidt G; Cao R; Müller M; Kirnbauer R; Rösl F; Hasche D
    Front Immunol; 2022; 13():1010790. PubMed ID: 36263027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoforms of the Papillomavirus Major Capsid Protein Differ in Their Ability to Block Viral Spread and Tumor Formation.
    Hasche D; Ahmels M; Braspenning-Wesch I; Stephan S; Cao R; Schmidt G; Müller M; Rösl F
    Front Immunol; 2022; 13():811094. PubMed ID: 35359995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A capture ELISA for monitoring papillomavirus-induced antibodies in Mastomys coucha.
    Schäfer K; Waterboer T; Rösl F
    J Virol Methods; 2010 Feb; 163(2):216-21. PubMed ID: 19800367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serological markers for papillomavirus infection and skin tumour development in the rodent model Mastomys coucha.
    Schäfer K; Neumann J; Waterboer T; Rösl F
    J Gen Virol; 2011 Feb; 92(Pt 2):383-94. PubMed ID: 20965987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal model.
    Vinzón SE; Braspenning-Wesch I; Müller M; Geissler EK; Nindl I; Gröne HJ; Schäfer K; Rösl F
    PLoS Pathog; 2014 Feb; 10(2):e1003924. PubMed ID: 24586150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
    Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
    J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of Mastomys natalensis papillomavirus in multiple organs identifies novel targets for infection.
    Nafz J; Köhler A; Ohnesorge M; Nindl I; Stockfleth E; Rösl F
    J Gen Virol; 2007 Oct; 88(Pt 10):2670-2678. PubMed ID: 17872518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in L2-based human papillomavirus (HPV) vaccines.
    Schellenbacher C; Roden RBS; Kirnbauer R
    Virus Res; 2017 Mar; 231():166-175. PubMed ID: 27889616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.
    Pouyanfard S; Spagnoli G; Bulli L; Balz K; Yang F; Odenwald C; Seitz H; Mariz FC; Bolchi A; Ottonello S; Müller M
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rodent Papillomaviruses.
    Uberoi A; Lambert PF
    Viruses; 2017 Nov; 9(12):. PubMed ID: 29186900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptome analysis of Mastomys natalensis papillomavirus in productive lesions after natural infection.
    Salvermoser M; Chotewutmontri S; Braspenning-Wesch I; Hasche D; Rösl F; Vinzón SE
    J Gen Virol; 2016 Jul; 97(7):1658-1669. PubMed ID: 27043420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
    J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
    [No Abstract]   [Full Text] [Related]  

  • 14. Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?
    Yadav R; Zhai L; Tumban E
    Viruses; 2019 Dec; 12(1):. PubMed ID: 31877975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).
    Huber B; Schellenbacher C; Shafti-Keramat S; Jindra C; Christensen N; Kirnbauer R
    PLoS One; 2017; 12(1):e0169533. PubMed ID: 28056100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
    Godi A; Boampong D; Elegunde B; Panwar K; Fleury M; Li S; Zhao Q; Xia N; Christensen ND; Beddows S
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
    Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
    J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interplay of UV and cutaneous papillomavirus infection in skin cancer development.
    Hasche D; Stephan S; Braspenning-Wesch I; Mikulec J; Niebler M; Gröne HJ; Flechtenmacher C; Akgül B; Rösl F; Vinzón SE
    PLoS Pathog; 2017 Nov; 13(11):e1006723. PubMed ID: 29190285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.
    Roden RB; Greenstone HL; Kirnbauer R; Booy FP; Jessie J; Lowy DR; Schiller JT
    J Virol; 1996 Sep; 70(9):5875-83. PubMed ID: 8709207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of Fc Domain and Exudation in L2 Antibody-Mediated Protection against Human Papillomavirus.
    Wang JW; Wu WH; Huang TC; Wong M; Kwak K; Ozato K; Hung CF; Roden RBS
    J Virol; 2018 Aug; 92(15):. PubMed ID: 29743371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.